Trust Co. of Toledo NA OH decreased its position in shares of Danaher Co. (NYSE:DHR) by 2.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 37,483 shares of the conglomerate’s stock after selling 794 shares during the quarter. Danaher makes up approximately 1.5% of Trust Co. of Toledo NA OH’s portfolio, making the stock its 11th largest holding. Trust Co. of Toledo NA OH’s holdings in Danaher were worth $8,437,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of DHR. Brasada Capital Management LP boosted its stake in shares of Danaher by 40.9% during the third quarter. Brasada Capital Management LP now owns 49,539 shares of the conglomerate’s stock worth $10,667,000 after buying an additional 14,384 shares during the period. First City Capital Management Inc. acquired a new stake in shares of Danaher during the third quarter worth about $272,000. Cubist Systematic Strategies LLC boosted its stake in shares of Danaher by 123.7% during the third quarter. Cubist Systematic Strategies LLC now owns 12,393 shares of the conglomerate’s stock worth $2,669,000 after buying an additional 6,853 shares during the period. Great West Life Assurance Co. Can lifted its position in Danaher by 1.0% in the third quarter. Great West Life Assurance Co. Can now owns 554,877 shares of the conglomerate’s stock valued at $119,454,000 after purchasing an additional 5,582 shares during the period. Finally, Sunbelt Securities Inc. lifted its position in Danaher by 8.8% in the third quarter. Sunbelt Securities Inc. now owns 5,412 shares of the conglomerate’s stock valued at $1,170,000 after purchasing an additional 440 shares during the period. 78.00% of the stock is currently owned by institutional investors.
A number of equities research analysts recently commented on the stock. Barclays assumed coverage on shares of Danaher in a research report on Monday, March 8th. They issued an “overweight” rating and a $260.00 price objective for the company. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating and set a $228.00 price objective for the company. in a research report on Tuesday, March 16th. Finally, Credit Suisse Group raised their price objective on shares of Danaher from $260.00 to $264.00 and gave the company an “outperform” rating in a research report on Thursday, January 14th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Danaher has an average rating of “Buy” and a consensus price target of $236.47.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, January 28th. The conglomerate reported $2.08 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.84 by $0.24. Danaher had a net margin of 18.05% and a return on equity of 12.94%. The business had revenue of $6.76 billion during the quarter, compared to analysts’ expectations of $6.62 billion. During the same period last year, the company posted $1.28 EPS. The company’s revenue was up 38.9% on a year-over-year basis. As a group, equities research analysts predict that Danaher Co. will post 6.05 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 30th. Shareholders of record on Friday, March 26th will be paid a $0.21 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.18. This represents a $0.84 annualized dividend and a yield of 0.36%. The ex-dividend date is Thursday, March 25th. Danaher’s payout ratio is presently 19.00%.
In other Danaher news, SVP Angela S. Lalor sold 6,437 shares of Danaher stock in a transaction that occurred on Friday, February 12th. The shares were sold at an average price of $244.70, for a total value of $1,575,133.90. Following the completion of the sale, the senior vice president now directly owns 25,148 shares of the company’s stock, valued at approximately $6,153,715.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.70% of the stock is currently owned by insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.